A human tumour-derived mutant p53 protein induces a p34cdc2 reversible growth arrest in fission yeast.

Abstract:

:We have expressed wild-type and human tumour-derived mutant p53 cDNA genes in the fission yeast Schizosaccharomyces pombe. In the case of one mutant this resulted in a growth arrest of recipient yeast cells. In contrast, wild-type p53 and three other mutant proteins tested did not block outgrowth of colonies. Human and yeast cdc2 acted as functionally equivalent extragenic suppressors of the mutant-induced growth arrest allowing the establishment of viable p53 expressor strains. In cotransformation assays the mutant allele was found to be dominant over wt p53. Our results provide the first evidence of a functional relationship between p53 and p34cdc2 in an in-vivo system and suggest that the wide variety of mutant proteins present in human tumours may fall into functionally distinct subclasses.

journal_name

Oncogene

journal_title

Oncogene

authors

Wagner P,Simanis V,Maimets T,Keenan E,Addison C,Brain R,Grimaldi M,Sturzbecher HW,Jenkins J

subject

Has Abstract

pub_date

1991-09-01 00:00:00

pages

1539-47

issue

9

eissn

0950-9232

issn

1476-5594

journal_volume

6

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • BPTF regulates growth of adult and pediatric high-grade glioma through the MYC pathway.

    abstract::High-grade gliomas (HGG) afflict both children and adults and respond poorly to current therapies. Epigenetic regulators have a role in gliomagenesis, but a broad, functional investigation of the impact and role of specific epigenetic targets has not been undertaken. Using a two-step, in vitro/in vivo epigenomic shRNA...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-1125-7

    authors: Green AL,DeSisto J,Flannery P,Lemma R,Knox A,Lemieux M,Sanford B,O'Rourke R,Ramkissoon S,Jones K,Perry J,Hui X,Moroze E,Balakrishnan I,O'Neill AF,Dunn K,DeRyckere D,Danis E,Safadi A,Gilani A,Hubbell-Engler B,Nus

    更新日期:2020-03-01 00:00:00

  • Target disruption of the mutant beta-catenin gene in colon cancer cell line HCT116: preservation of its malignant phenotype.

    abstract::Most colorectal carcinomas harbor genetic alterations that result in stabilization of beta-catenin. A colorectal carcinoma cell line, HCT116, which has both mutated and wild-type beta-catenin genes, was engineered by homologous recombination to investigate the significance of beta-catenin gene mutation. As expected, t...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205756

    authors: Sekine S,Shibata T,Sakamoto M,Hirohashi S

    更新日期:2002-08-29 00:00:00

  • Correction: Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression.

    abstract::After publication of this Article, the Authors noticed errors in some of the Figures. In Figures 2e, 2f-g, 4a, 4j, 5a and 6b, unmatched β-actin was inadvertently used as loading control for the immunoblots. These have been corrected using repeat data from a similar set of samples and the revised Figures containing mat...

    journal_title:Oncogene

    pub_type: 已发布勘误

    doi:10.1038/s41388-020-1283-7

    authors: Vantaku V,Putluri V,Bader DA,Maity S,Ma J,Arnold JM,Rajapakshe K,Donepudi SR,von Rundstedt FC,Devarakonda V,Dubrulle J,Karanam B,McGuire SE,Stossi F,Jain AK,Coarfa C,Cao Q,Sikora AG,Villanueva H,Kavuri SM,Lotan Y

    更新日期:2020-10-01 00:00:00

  • Targeting WNT1-inducible signaling pathway protein 2 alters human breast cancer cell susceptibility to specific lysis through regulation of KLF-4 and miR-7 expression.

    abstract::The molecular basis for the resistance of tumor cells to cell-mediated cytotoxicity remains poorly understood and thus poses a major challenge for cancer immunotherapy. The present study was designed to determine whether the WNT1-inducible signaling pathway protein 2 (WISP2, also referred to as CCN5), a key regulator ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.151

    authors: Akalay I,Tan TZ,Kumar P,Janji B,Mami-Chouaib F,Charpy C,Vielh P,Larsen AK,Thiery JP,Sabbah M,Chouaib S

    更新日期:2015-04-23 00:00:00

  • Apoptotic cues from the extracellular matrix: regulators of angiogenesis.

    abstract::A variety of factors cooperate to regulate neovessel formation and persistence. Proangiogenic growth factors have remained an area of intense interest due to their capacity to promote endothelial cell (EC) proliferation and to initiate the angiogenic program. These growth factors are associated with increased cell sur...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1207110

    authors: Stupack DG,Cheresh DA

    更新日期:2003-12-08 00:00:00

  • Isolation of two novel ras genes in Dictyostelium discoideum; evidence for a complex, developmentally regulated ras gene subfamily.

    abstract::In Dictyostelium discoideum, three ras genes (rasD, rasG and rasB) and one ras-related gene (rap1) have been previously isolated and characterized, and the deduced amino acid sequence of their predicted protein products share at least 50% sequence identity with the human H-Ras protein. We have now cloned and character...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Daniel J,Bush J,Cardelli J,Spiegelman GB,Weeks G

    更新日期:1994-02-01 00:00:00

  • Fibroblasts drive an immunosuppressive and growth-promoting microenvironment in breast cancer via secretion of Chitinase 3-like 1.

    abstract::Cancer-Associated Fibroblasts (CAFs) are the most prominent stromal cell type in breast tumors. CAFs promote tumor growth and metastasis by multiple mechanisms, including by mediating tumor-promoting inflammation. Immune modulation in the tumor microenvironment plays a central role in determining disease outcome. Howe...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.65

    authors: Cohen N,Shani O,Raz Y,Sharon Y,Hoffman D,Abramovitz L,Erez N

    更新日期:2017-08-01 00:00:00

  • Skp2-mediated ubiquitination and mitochondrial localization of Akt drive tumor growth and chemoresistance to cisplatin.

    abstract::The E3 ligase S-phase kinase-associated protein 2(Skp2) is overexpressed in human cancers and correlated with poor prognosis, but its contributions to tumorigenesis and chemoresistance in nasopharyngeal carcinoma (NPC) are not evident. Herein we show that Skp2 is highly expressed in NPC tumor tissues and cell lines. K...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0955-7

    authors: Yu X,Wang R,Zhang Y,Zhou L,Wang W,Liu H,Li W

    更新日期:2019-12-01 00:00:00

  • Molecular cloning of a recombinant retrovirus carrying a mutated envAKR-mycMH2 fusion gene immortalizing cells of the monocytic-macrophage lineage.

    abstract::The VN-11 recombinant retroviruses, originally generated by co-transfection of the avian MH2 and AKRv viral genomes, were molecularly cloned from an infected mouse cell line named N11. The analysis of the proviral genome sequence from one of these recombinants showed a possible envAKR-mycMH2 fusion. Point mutations we...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Sassano M,Granucci F,Seveso M,Marconi G,Foti M,Ricciardi-Castagnoli P

    更新日期:1994-05-01 00:00:00

  • Deletion of either C-terminal transactivation subdomain enhances the in vitro transforming activity of human transcription factor REL in chicken spleen cells.

    abstract::The REL gene is amplified in many human B-cell lymphomas and we have previously shown that expression of REL from a retroviral vector can malignantly transform chicken spleen cells in vitro. To identify REL protein functions necessary for malignant transformation, we have performed deletion analysis on REL sequences e...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206801

    authors: Starczynowski DT,Reynolds JG,Gilmore TD

    更新日期:2003-10-09 00:00:00

  • Structure and transcription of the genomic locus encoding murine c-Mpl, a receptor for thrombopoietin.

    abstract::We have cloned and characterised the murine gene encoding c-Mpl, a receptor for thrombopoietin and member of the hematopoietin receptor superfamily. The gene encompasses 15 kb of the mouse genome and the organisation of its 12 exons conforms closely to the pattern observed for the genes of other hematopoietin receptor...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Alexander WS,Dunn AR

    更新日期:1995-02-16 00:00:00

  • Altered expression of Erg and Ets-2 transcription factors is associated with genetic changes at 21q22.2-22.3 in immortal and cervical carcinoma cell lines.

    abstract::Human Papillomavirus (HPV) type 16 is the most frequently detected HPV in cervical cancer. Although epidemiologic and experimental evidence indicates a prominent role for HPV infection in the development of this disease, other factors are also involved. Altered expression of the ets family transcription factors erg an...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201058

    authors: Simpson S,Woodworth CD,DiPaolo JA

    更新日期:1997-05-08 00:00:00

  • Adenovirus-mediated transfer of wild-type p53 gene sensitizes TNF resistant MCF7 derivatives to the cytotoxic effect of this cytokine: relationship with c-myc and Rb.

    abstract::Tumor suppressor p53 is a nuclear transcription factor that blocks cell cycle progression and induces apoptosis. We have previously shown that the MCF7 resistance to the cytotoxic action of TNF correlates with p53 mutations. In the present study, we used a recombinant adenovirus carrying a wild-type p53 gene (Adwtp53)...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202919

    authors: Ameyar M,Shatrov V,Bouquet C,Capoulade C,Cai Z,Stancou R,Badie C,Haddada H,Chouaib S

    更新日期:1999-09-23 00:00:00

  • A possible role for c-Myc oncoproteins in post-transcriptional regulation of ribosomal RNA.

    abstract::Overexpression of members of the myc family of oncogenes contributes to the development of many vertebrate malignancies. Although several functions for myc gene products have been proposed, the targets for Myc activity during oncogenesis or normal development remain to be identified. Oocytes of Xenopus laevis, which a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Gibson AW,Ye R,Johnston RN,Browder LW

    更新日期:1992-11-01 00:00:00

  • Pot1 OB-fold mutations unleash telomere instability to initiate tumorigenesis.

    abstract::Chromosomal aberrations are a hallmark of human cancers, with complex cytogenetic rearrangements leading to genetic changes permissive for cancer initiation and progression. Protection of Telomere 1 (POT1) is an essential component of the shelterin complex and functions to maintain chromosome stability by repressing t...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.405

    authors: Gu P,Wang Y,Bisht KK,Wu L,Kukova L,Smith EM,Xiao Y,Bailey SM,Lei M,Nandakumar J,Chang S

    更新日期:2017-04-06 00:00:00

  • Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players.

    abstract::Long-lived species Homo sapiens have evolved robust protection mechanisms against cancer by repressing telomerase and maintaining short telomeres, thereby delaying the onset of the majority of cancer types until post-reproductive age. Indeed, telomerase is silent in most differentiated human cells, predominantly due t...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/s41388-019-0872-9

    authors: Yuan X,Larsson C,Xu D

    更新日期:2019-08-01 00:00:00

  • LOT1 is a growth suppressor gene down-regulated by the epidermal growth factor receptor ligands and encodes a nuclear zinc-finger protein.

    abstract::We previously reported cloning the rLot1 gene, and its human homolog (hLOT1), through analysis of differential gene expression in normal and malignant rat ovarian surface epithelial cells. Both human and rat ovarian carcinoma cell lines exhibited lost or decreased expression of this gene. Interestingly, the LOT1 gene ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203067

    authors: Abdollahi A,Bao R,Hamilton TC

    更新日期:1999-11-11 00:00:00

  • Structural and functional involvement of p53 in BER in vitro and in vivo.

    abstract::p53 is involved in several DNA repair pathways. Some of these require the specific transactivation of p53-dependent genes and others involve direct interactions between the p53 protein and DNA repair associated proteins. Previously, we have shown that p53 acts directly in Base Excision Repair (BER) when assayed under ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204120

    authors: Offer H,Milyavsky M,Erez N,Matas D,Zurer I,Harris CC,Rotter V

    更新日期:2001-02-01 00:00:00

  • Analysis of dimerization and DNA binding functions in Fos and Jun by domain-swapping: involvement of residues outside the leucine zipper/basic region.

    abstract::The products of two cellular proto-oncogenes c-fos and c-jun form a heterodimeric complex that contribute to the DNA-binding activity referred to as AP-1 (activator protein-1). Two domains have been proposed to be required for heterodimer formation and protein-DNA complex formation. The leucine zipper domain mediated ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Cohen DR,Curran T

    更新日期:1990-06-01 00:00:00

  • Systems biology analysis of G protein and MAP kinase signaling in yeast.

    abstract::Approximately a third of all drugs act by binding directly to cell surface receptors coupled to G proteins. Other drugs act indirectly on these same pathways, for example, by inhibiting neurotransmitter reuptake or by blocking the inactivation of intracellular second messengers. These drugs have revolutionized the tre...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1210416

    authors: Hao N,Behar M,Elston TC,Dohlman HG

    更新日期:2007-05-14 00:00:00

  • Expression of SCC-S2, an antiapoptotic molecule, correlates with enhanced proliferation and tumorigenicity of MDA-MB 435 cells.

    abstract::SCC-S2/GG2-1/NDED is a recently discovered antiapoptotic molecule induced by the activation of the transcription factor NF-kappaB. Here we have examined a role of SCC-S2 in cell growth regulation in vitro and in vivo. Western blotting using an antipeptide antibody revealed endogenous SCC-S2 as a approximately 21 kDa c...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207123

    authors: Kumar D,Gokhale P,Broustas C,Chakravarty D,Ahmad I,Kasid U

    更新日期:2004-01-15 00:00:00

  • Chemosensitization of HER-2/neu-overexpressing human breast cancer cells to paclitaxel (Taxol) by adenovirus type 5 E1A.

    abstract::Breast cancer cells that overexpress HER-2/neu are more resistant to chemotherapeutic agents such as paclitaxel (Taxol) and docetaxel (Taxotere) than those that do not overexpress HER-2/neu. In previous work, we showed that the adenovirus type 5 E1A can repress HER-2/neu expression at the transcriptional level. Here w...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201250

    authors: Ueno NT,Yu D,Hung MC

    更新日期:1997-08-18 00:00:00

  • Aberrant activation of ALK kinase by a novel truncated form ALK protein in neuroblastoma.

    abstract::Anaplastic lymphoma kinase (ALK) was originally identified from a rare subtype of non-Hodgkin's lymphomas carrying t(2;5)(p23;q35) translocation, where ALK was constitutively activated as a result of a fusion with nucleophosmin (NPM). Aberrant ALK fusion proteins were also generated in inflammatory fibrosarcoma and a ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.616

    authors: Okubo J,Takita J,Chen Y,Oki K,Nishimura R,Kato M,Sanada M,Hiwatari M,Hayashi Y,Igarashi T,Ogawa S

    更新日期:2012-11-01 00:00:00

  • Activation of peroxisome proliferator-activated receptor-gamma stimulates the growth arrest and DNA-damage inducible 153 gene in non-small cell lung carcinoma cells.

    abstract::Activation of peroxisome proliferator-activated receptor (PPAR)-gamma by the thiazolidinedione (TZD) class of antidiabetic drugs elicits growth inhibition in a variety of malignant tumors. We clarified the effects of TZDs on growth of human non-small cell lung carcinoma (NSCLC) cells that express endogenous PPAR-gamma...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205279

    authors: Satoh T,Toyoda M,Hoshino H,Monden T,Yamada M,Shimizu H,Miyamoto K,Mori M

    更新日期:2002-03-28 00:00:00

  • Notch-induced mammary tumorigenesis does not involve the lobule-limited epithelial progenitor.

    abstract::The mouse mammary epithelial cell hierarchy contains both multipotent stem cell as well as lineage-limited duct and lobular progenitor cell functions. The latter-also termed parity-identified mammary epithelial cells (PI-MECs)-are marked by beta-galactosidase (β Gal) expression following pregnancy and involution in wh...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.215

    authors: Bruno RD,Boulanger CA,Smith GH

    更新日期:2012-01-05 00:00:00

  • Oligomerization of p53 is necessary to inhibit its transcriptional transactivation property at high protein concentration.

    abstract::We have previously shown that transactivation by tumor suppressor protein p53 can be inhibited in vivo at elevated protein concentrations. In this study we characterize the structural requirements of this function. We show that oligomerization domain of p53 is involved in loss of transactivation at high protein concen...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201749

    authors: Kristjuhan A,Jaks V,Rimm I,Tooming T,Maimets T

    更新日期:1998-05-07 00:00:00

  • Induction of epithelial abnormalities that resemble human breast lesions by the expression of the neu/erbB-2 oncogene in reconstituted mouse mammary gland.

    abstract::We have developed a transplantation system that allows us to introduce oncogenes into mouse mammary epithelial cells in culture and then to reconstitute an epithelial tree in vivo from the genetically altered cells. Introduction of the neu oncogene, a transforming homologue of the human proto-oncogene c-erbB-2, produc...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Bradbury JM,Arno J,Edwards PA

    更新日期:1993-06-01 00:00:00

  • AP-1 complex is effector of Hox-induced cellular proliferation and transformation.

    abstract::Hox gene products, initially characterized as master regulators of embryonic patterning, are also required for proper functioning of adult tissues. There is also a growing body of evidence that links Hox proteins to regulation of cellular proliferation/transformation. However, the underlying molecular mechanisms of Ho...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203897

    authors: Krosl J,Sauvageau G

    更新日期:2000-10-26 00:00:00

  • Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomas.

    abstract::The MET oncogene encodes the receptor for HGF/Scatter Factor, known to control cell motility and invasion in epithelial cells. We report that the Met/HGF receptor, absent in differentiated adult skeletal muscles, is aberrantly expressed in clinical samples and in established cell lines of human rhadbomyosarcomas. In b...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Ferracini R,Olivero M,Di Renzo MF,Martano M,De Giovanni C,Nanni P,Basso G,Scotlandi K,Lollini PL,Comoglio PM

    更新日期:1996-04-18 00:00:00

  • Over-representation of a germline variant in the gene encoding RET co-receptor GFRalpha-1 but not GFRalpha-2 or GFRalpha-3 in cases with sporadic medullary thyroid carcinoma.

    abstract::In contrast to the hereditary form of medullary thyroid carcinoma (MTC), little is known about the etiology of sporadic MTC. Somatic gain-of-function mutations in the RET proto-oncogene, encoding a receptor tyrosine kinase, are found in an average of 40% of sporadic MTC. We analysed 31 sporadic MTC for somatic and ger...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204289

    authors: Gimm O,Dziema H,Brown J,Hoang-Vu C,Hinze R,Dralle H,Mulligan LM,Eng C

    更新日期:2001-04-19 00:00:00